Last reviewed · How we verify
PA21 with food and Losartan 2 hours later — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
PA21 with food and Losartan 2 hours later (PA21 with food and Losartan 2 hours later) — Vifor Pharma.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| PA21 with food and Losartan 2 hours later TARGET | PA21 with food and Losartan 2 hours later | Vifor Pharma | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- PA21 with food and Losartan 2 hours later CI watch — RSS
- PA21 with food and Losartan 2 hours later CI watch — Atom
- PA21 with food and Losartan 2 hours later CI watch — JSON
- PA21 with food and Losartan 2 hours later alone — RSS
Cite this brief
Drug Landscape (2026). PA21 with food and Losartan 2 hours later — Competitive Intelligence Brief. https://druglandscape.com/ci/pa21-with-food-and-losartan-2-hours-later. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab